SEC filings
Insulet Corporation (PODD)
Recent filings Insulet Corporation made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001145197All filings on SEC.gov
10-QQuarterly report
Quarterly report
Insulet Corporation reported third-quarter 2026 revenue of $842.0 million, up 19.2% from a year earlier, on growth in its Omnipod customer base, and nine-month revenue of $2.405 billion, up 25.0%. …
8-KCurrent report
Results of Operations and Financial Condition; Regulation FD Disclosure
Insulet Corporation reported third-quarter 2026 revenue of $842.0 million, up 19.2% year over year, and net income of $141.1 million ($2.03 per diluted share), while raising its full-year 2026 revenue and margin guidance. …
8-KCurrent report
Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Insulet Corporation entered into the Ninth Amendment to its credit agreement on September 21, 2026, refinancing $475 million of existing term loans with new term loans priced 0.25 percentage points lower and increasing revolving credit…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Insulet Corporation's Talent and Compensation Committee approved a Nonqualified Deferred Compensation Plan on September 14, 2026, effective January 1, 2027, allowing a select group of management and highly compensated employees, including…
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Timothy J. Scannell stepped down from Insulet Corporation's board of directors for health reasons, effective September 3, 2026, after 12 years of service including 7 as chairman, and Michael R. …
10-QQuarterly report
Quarterly report
Insulet Corporation reported total revenue of $801.7 million for the quarter ended June 30, 2026, up 23.5% from a year earlier, as Omnipod product revenue rose 24.6% to $795.9 million. …
8-KCurrent report
Results of Operations and Financial Condition
Insulet reported second-quarter 2026 revenue of $801.7 million, up 23.5% year over year (22.7% in constant currency), net income of $95.0 million, or $1.37 per diluted share, and adjusted EPS of $1.66. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Insulet Corporation in Readster
Add Insulet Corporation to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.